CEO Interview: Dr. Phillip Frost, Opko Health (OPK)
Opko Health (OPK) is headed by Dr. Phillip Frost, who has had great success with founding and selling pharma companies, two of which he sold at rich premiums; one had gained 6,000%. Opko has risen 55% in less than three months and is a huge player in diagnostic testing. It is developing a drug to reduce nausea in chemotherapy patients and has developed a Vitamin D treatment for those with renal disease. OPK has made successful acquisitions, including Claros Diagnostics. Cramer thinks Dr. Frost and Opko have a great track record of success.